Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ECLIP-Seq of endogenous/exogenous MYC in MCF-7 cells.

ABSTRACT: eCLIP-Seq of endogenous/exogenous MYC in MCF-7 cells.

PROVIDER: PRJNA824126 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18668725_1.fastq.gz	Fastqsanger.gz
	SRR18668725_2.fastq.gz	Fastqsanger.gz
	SRR18668726_1.fastq.gz	Fastqsanger.gz
	SRR18668726_2.fastq.gz	Fastqsanger.gz
	SRR18668727_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

eCLIP-Seq of endogenous/exogenous MYC in MCF-7 cells.

Project description:MYC binds to thousands of promoters and exerts an amplification effect on expression of most genes. Meanwhile, MYC drives tumourigenesis through the regulation of a unique set of cancer-specific targets that differ from its targets in normal cells. The discrepancy in MYC-mediated gene regulation in tumours versus normal cells has not been fully elucidated. In this study, we discovered that MYC protein has a broad RNA binding spectrum including promoter-associated RNAs (paRNAs) and enhancer RNAs (eRNAs). MYC RNA binding peaks colocalize with its DNA binding sites, but they are not dependent on its HLHLZ domain or transactivation domain. By integrating multiple dimensional data sets from cancer cells and tumour samples, we show that the MYC-bound paRNAs and eRNAs can shape MYC chromatin interaction to regulate gene transcription. Finally, we identified and characterized a novel MYC-bound eRNA, which we refer to as MERG1, that plays essential roles in the ERα+ breast cancer tumourigenesis. Mechanistically, MERG1 interacts with MYC and enhances MYC binding to the enhancer and promoter of the GREB1 gene. This process specifically amplifies expression of the MYC target gene GREB1 and accelerates tumour progression. Our study demonstrates that MYC interaction with paRNAs and eRNAs contribute to its specific amplification of gene expression in tumourigenesis.

2025-04-30 | GSE200344 | GEO

Enhanced CLIP-Seq (eCLIP-Seq) of endogenous MYC in different cell lines

Project description:Enhanced CLIP-Seq (eCLIP-Seq) of endogenous MYC in different cell lines

| PRJNA1062076 | ENA

Novel MYC-driven medulloblastoma models generated by CRISPR activation of endogenous Myc

Project description:Myc-driven Group 3 medulloblastoma (MB) is the most aggressive tumor among the four subgroups classified by transcriptome, genomic landscape and clinical outcomes. So far in all available mouse Group 3 models, the constitutive ectopic Myc expression was under control of LTR element or other exogenous promoters within the vectors, which were randomly inserted into the genome with multiple copies. Here we are deploying nuclease deficient CRISPR/dCas9-based transactivator that is targeted to promoter DNA sequences by specific guide RNA to force the transcriptional activation of endogenous Myc in p53-/-;cdkn2c-/- neurospheres cells. A combination of three sgRNAs together with dCas9-VP64 induced the highest expression of endogenous Myc. When the targeted cells were transplanted to the cortex of recipients, tumors arose fully recapitulate the Group 3 MB in human. This novel mouse model should significantly strengthen our understanding and treatment of the Myc-driven Group 3 medulloblastoma.

2018-06-19 | GSE102037 | GEO

RNA-seq analysis of MCF-10A human mammary epithelial cells following MYC activation

Project description:We profiled gene expression and splicing changes in MCF-10A human mammary epithelial cells expressing MYC fused to a portion of estrogen receptor (MYC-ER) (Eilers et al., 1989; Littlewood et al., 1995). We performed RNA-seq, in triplicate, on 3D-grown MCF-10A MYC-ER cells at 0, 8, and 24 hours (h) after 4-OHT-induced MYC activation. As a control for 4-OHT-induced effects, 3D-grown parental MCF-10A cells lacking the MYC-ER fusion protein were treated with 4-OHT at the same timepoints.

2022-07-11 | GSE181968 | GEO

Estrogen- and Myc-regulated genes in MCF-7 breast cancer cells

Project description:Estrogen-responsive genes were identified by transcript profiling of estrogen-treated MCF-7 breast cancer cells. The gene expression profile generated after estrogen treatment was compared with that following inducible expression of c-Myc or c-Zip (a deletion mutant of c-Myc that lacks the N-terminal transactivation domains) in clonal MCF-7 cell lines. Keywords: Single time point

2008-08-21 | GSE11791 | GEO

Bioinformatic analysis of endogenous and exogenous small RNAs on lipoproteins

Project description:Bioinformatic analysis of endogenous and exogenous small RNAs on lipoproteins

| PRJNA431602 | ENA

innate immune cell memory induced by endogenous and exogenous triggers

Project description:innate immune cell memory induced by endogenous and exogenous triggers

| PRJNA1143447 | ENA

ChIP-Seq with reference exogenous genome (ChIP-Rx) of MAX in U2OS-MYC-KO-MYC-Tet-On cells with exogenous wild-type and mutant MYC expression

Project description:ChIP-Seq with reference exogenous genome (ChIP-Rx) of MAX in U2OS-MYC-KO-MYC-Tet-On cells with exogenous wild-type and mutant MYC expression

| PRJNA1143039 | ENA

Novel MYC-driven medulloblastoma models generated by CRISPR activation of endogenous Myc

Project description:Myc-driven Group 3 (G3) medulloblastoma (MB) is the most aggressive tumor among the four subgroups classified by transcriptome, genomic landscape and clinical outcomes. Several successful mouse models have been developed to recapitulate G3 MB tumor development; however, all models currently used facilitate tumorigenesis by constitutive ectopic expression of exogenously regulated Myc randomly integrated in multiple events into the genome. To overcome limitations of ectopically expressed Myc models, we used nuclease deficient CRISPR/dCas9-based transactivators in combination with specific single guide RNA (sgRNA) to force the transcriptional activation of endogenous Myc in Trp53-null neurosphere cells followed by orthotopic transplantations. Combination of three sgRNAs with dCas9-VP64 induced endogenous Myc expression and formed large cell anaplastic MBs which recapitulated the molecular characteristics of other mouse G3 MBs. This novel model more closely mimics human Myc-driven G3 MB disease development, and will be a valuable tool for future pre-clinical and therapeutic studies.

2018-06-12 | GSE102096 | GEO

RNA-Seq of U2OS-MYC-KO-MYC-Tet-On cells with exogenous wild-type and mutant MYC expression

Project description:RNA-Seq of U2OS-MYC-KO-MYC-Tet-On cells with exogenous wild-type and mutant MYC expression

| PRJNA1143041 | ENA